EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock

Natalie Y Leung iD, Charlene Dinh, Lee Nguyen iD, Mira Bakas iD, Wan-Ting Huang

Perfusion · 2026-07 · 41 (5) · 585-592

DOI: 10.1177/02676591261432003 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Perfusion, online erschienen am 10.03.2026. Verfasst von Natalie Y Leung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, UC San Diego Health, San Diego, CA, USA. Hauptthemen laut MEDLINE: Hydroxocobalamin, Methylene Blue, Shock, Vasoconstrictor Agents. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although methylene blue and hydroxocobalamin are commonly used as rescue treatments for refractory shock, large-scale head-to-head trials comparing these agents are lacking. This study aimed to evaluate their effects on vasopressor doses in patients with refractory shock.

Methods

A retrospective observational study was conducted among patients who received methylene blue or hydroxocobalamin for refractory shock. The primary endpoint was the change in vasopressor dose 24 hours after administration. Secondary outcomes included changes in mean arterial pressure and vasopressor dose over 24 hours (0, 6, 12, and 24 hours), time to vasopressor discontinuation, vasopressor-free days at 28 days, ICU and hospital length of stay, and hospital mortality.

Results

A total of 303 patients who received methylene blue (n=269) or hydroxocobalamin (n=34) were included. The mean reduction in vasopressor doses over 24 hours was similar (methylene blue 0.36 mcg/kg/min vs hydroxocobalamin 0.33 mcg/kg/min, p=0.588). The mean reduction from baseline was significant in both groups at 6, 12, and 24 hours after administration (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxocobalaminMethylene BlueShockVasoconstrictor AgentsHumansFemaleRetrospective StudiesMaleMiddle AgedAgedHospital Mortality

Stichwörter der Autor:innen

hydroxocobalaminmethylene bluesepsisshockvasopressors

Substanzen

HydroxocobalaminMethylene BlueVasoconstrictor Agents

Autor:innen und Institutionen

  • Department of Pharmacy, UC San Diego Health, San Diego, CA, USA.
  • Department of Pharmacy, UCI Health, Orange, CA, USA.
  • Department of Clinical Pharmacy Practice, UCI School of Pharmacy and Pharmaceutical Sciences, Irvine, CA, USA.

ORCID-Profile: Natalie Y Leung, Lee Nguyen, Mira Bakas

Zitieren

APA

Leung, N. Y., Dinh, C., Nguyen, L., Bakas, M., & Huang, W. T. (2026). A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock. Perfusion, 41(5), 585-592. https://doi.org/10.1177/02676591261432003

Vancouver

Leung NY, Dinh C, Nguyen L, Bakas M, Huang WT. A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock. Perfusion. 2026;41(5):585-592. doi:10.1177/02676591261432003

BibTeX
@article{Leung2026,
  author = {Leung, Natalie Y and Dinh, Charlene and Nguyen, Lee and Bakas, Mira and Huang, Wan-Ting},
  title = {A two-center comparison of the efficacy of methylene blue and hydroxocobalamin for the treatment of refractory shock},
  journal = {Perfusion},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {585--592},
  doi = {10.1177/02676591261432003}
}
Kostenlos starten →